Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unicenta vs Melsmon in Menopausal Syndrome
NCT01931748Phase 3Completed
- Sponsor
- Unimed Pharmaceutical Inc.
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Unicenta in menopause, sponsored by Unimed Pharmaceutical Inc.. Started Apr 2013; status: completed.
02
Drugs
Unicenta
03
Conditions
menopause
Beyond the preview
Go deeper on NCT01931748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931748.